GleamWall
中文EN

MD Pediatrix Medical Group, Inc.

Services-Hospitals · NYSE · SEC CIK 893949 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY1.9%
TTM net income YoY-7.5%
TTM EPS YoY-4.2%
Revenue 3-yr CAGR-0.9%
Net income 3-yr CAGR17.1%

Margins

Gross margin—
Operating margin10.9%
Net margin7.7%
FCF margin—
EBITDA margin12.1%

Returns

ROE17.2%
ROA6.9%
ROIC (approx.)13.8%
Asset turnover0.90x

Leverage & solvency

Liabilities / assets60.3%
Debt / equity0.68x
Current ratio1.28x
Interest coverage6.38x

Cash quality & payout

Operating cash flow / net income1.51x
Accruals ratio-3.5%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$501.37M$487.78M$476.20M$493.77M$492.88M$468.84M$458.36M$502.36M
SG&A expense$62.70M$61.29M$60.27M$65.68M$60.79M$55.71M$58.60M$63.55M
Operating income$65.21M$56.92M$41.66M$48.79M$68.05M$59.87M$32.10M$39.29M
Interest expense$8.13M$8.17M$8.27M$8.74M$8.94M$9.13M$9.15M$9.71M
Pretax income$64.99M$54.00M$38.84M$45.59M$87.78M$54.97M$28.09M$33.33M
Income tax$18.00M$14.16M$9.27M$11.91M$16.07M$15.71M$7.35M$2.85M
Net income$46.99M$39.84M$29.57M$33.68M$71.71M$39.26M$20.74M$30.48M
EBITDA$71.45M$62.70M$47.78M$54.42M$73.60M$65.18M$37.43M$46.16M
EPS (basic)0.610.500.37—0.850.460.25—
EPS (diluted)0.590.490.36—0.840.460.24—
Weighted avg. shares (diluted)79.73M81.41M83.08M—85.61M85.53M85.43M—
Balance sheet
Cash & equivalents$311.92M$288.88M$205.78M$375.24M$340.06M$224.73M$98.98M$229.94M
Short-term investments$113.92M$115.32M$123.19M$124.48M$123.04M$123.59M$120.20M$118.57M
Receivables$231.82M$227.60M$224.80M$229.66M$231.12M$238.99M$242.53M$259.99M
Current assets$684.08M$660.14M$587.03M$763.51M$717.20M$613.05M$491.67M$639.61M
PP&E, net$37.24M$38.70M$41.09M$39.18M$38.64M$38.94M$38.22M$39.17M
Goodwill$1.27B$1.27B$1.27B$1.26B$1.26B$1.24B$1.24B$1.24B
Intangibles$13.10M$14.51M$15.94M$16.86M$14.80M$9.30M$10.39M$11.60M
Total assets$2.14B$2.13B$2.07B$2.25B$2.20B$2.10B$1.99B$2.15B
Current liabilities$535.73M$501.58M$442.64M$458.91M$392.55M$341.04M$271.05M$434.11M
Short-term debt$179.95M$186.18M$192.42M$26.81M$25.34M$23.68M$22.13M$20.55M
Long-term debt$397.77M$398.06M$398.35M$570.53M$577.17M$583.86M$590.48M$597.12M
Total debt$577.72M$584.24M$590.77M$597.34M$602.51M$607.55M$612.60M$617.66M
Total liabilities$1.29B$1.25B$1.19B$1.38B$1.31B$1.27B$1.20B$1.39B
Shareholders' equity$849.62M$880.98M$878.58M$865.85M$890.67M$833.75M$789.19M$764.94M
Net debt$265.80M$295.36M$384.99M$222.10M$262.45M$382.82M$513.63M$387.72M
Shares outstanding78.09M81.22M82.06M82.98M85.83M86.85M85.81M85.87M
Cash flow statement
Operating cash flow$117.31M$125.32M-$129.85M$114.10M$137.28M$137.17M-$117.46M$133.01M
Investing cash flow-$4.64M$6.02M-$11.98M-$10.28M$6.60M-$7.15M-$7.46M-$1.94M
Financing cash flow-$89.63M-$48.24M-$27.64M-$68.64M-$28.56M-$4.26M-$6.04M-$4.96M
Depreciation & amortization$6.24M$5.78M$6.12M$5.63M$5.55M$5.31M$5.33M$6.87M
Stock-based compensation$6.20M$5.08M$4.66M$5.34M$3.40M$2.00M$3.64M$2.74M
Share buybacks$83.04M$42.74M$21.45M$64.04M$20.87M$209,000$1.57M$643,000

Free plan shows the latest 8 periods; Pro shows all 70 🔒

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.